Literature DB >> 11100728

MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans.

R Ranganathan1, S C Cannon, H R Horvitz.   

Abstract

The neurotransmitter and neuromodulator serotonin (5-HT) functions by binding either to metabotropic G-protein-coupled receptors (for example, 5-HT1, 5-HT2, 5-HT4 to 5-HT7), which mediate 'slow' modulatory responses through numerous second messenger pathways, or to the ionotropic 5-HT3 receptor, a non-selective cation channel that mediates 'fast' membrane depolarizations. Here we report that the gene mod-1 (for modulation of locomotion defective) from the nematode Caenorhabditis elegans encodes a new type of ionotropic 5-HT receptor, a 5-HT-gated chloride channel. The predicted MOD-1 protein is similar to members of the nicotinic acetylcholine receptor family of ligand-gated ion channels, in particular to GABA (gamma-aminobutyric acid)- and glycine-gated chloride channels. The MOD-1 channel has distinctive ion selectivity and pharmacological properties. The reversal potential of the MOD-1 channel is dependent on the concentration of chloride ions but not of cations. The MOD-1 channel is not blocked by calcium ions or 5-HT3a-specific antagonists but is inhibited by the metabotropic 5-HT receptor antagonists mianserin and methiothepin. mod-1 mutant animals are defective in a 5-HT-mediated experience-dependent behaviour and are resistant to exogenous 5-HT, confirming that MOD-1 functions as a 5-HT receptor in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11100728     DOI: 10.1038/35044083

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  82 in total

Review 1.  Nematode cys-loop GABA receptors: biological function, pharmacology and sites of action for anthelmintics.

Authors:  Michael V Accardi; Robin N Beech; Sean G Forrester
Journal:  Invert Neurosci       Date:  2012-03-20

2.  Two types of chloride transporters are required for GABA(A) receptor-mediated inhibition in C. elegans.

Authors:  Andrew Bellemer; Taku Hirata; Michael F Romero; Michael R Koelle
Journal:  EMBO J       Date:  2011-03-22       Impact factor: 11.598

3.  Specific inhibition of the plasmodial surface anion channel by dantrolene.

Authors:  Godfrey Lisk; Myungsa Kang; Jamieson V Cohn; Sanjay A Desai
Journal:  Eukaryot Cell       Date:  2006-09-01

4.  Blocking of striated muscle degeneration by serotonin in C. elegans.

Authors:  Maité Carre-Pierrat; Marie-Christine Mariol; Lucie Chambonnier; Aurélie Laugraud; Fabienne Heskia; Jean Giacomotto; Laurent Ségalat
Journal:  J Muscle Res Cell Motil       Date:  2006-06-22       Impact factor: 2.698

5.  Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety.

Authors:  Young-jai You; Jeongho Kim; David M Raizen; Leon Avery
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

6.  Behavioral choice by presynaptic inhibition of tactile sensory terminals.

Authors:  Quentin Gaudry; William B Kristan
Journal:  Nat Neurosci       Date:  2009-10-04       Impact factor: 24.884

7.  SER-7, a Caenorhabditis elegans 5-HT7-like receptor, is essential for the 5-HT stimulation of pharyngeal pumping and egg laying.

Authors:  Robert J Hobson; Vera M Hapiak; Hong Xiao; Kara L Buehrer; Patricia R Komuniecki; Richard W Komuniecki
Journal:  Genetics       Date:  2005-10-03       Impact factor: 4.562

8.  An integrated serotonin and octopamine neuronal circuit directs the release of an endocrine signal to control C. elegans body fat.

Authors:  Tallie Noble; Jonathan Stieglitz; Supriya Srinivasan
Journal:  Cell Metab       Date:  2013-10-10       Impact factor: 27.287

9.  Evidence for a diverse Cys-loop ligand-gated ion channel superfamily in early bilateria.

Authors:  Joseph A Dent
Journal:  J Mol Evol       Date:  2006-04-01       Impact factor: 2.395

10.  The cys-loop ligand-gated ion channel gene family of Brugia malayi and Trichinella spiralis: a comparison with Caenorhabditis elegans.

Authors:  Sally M Williamson; Thomas K Walsh; Adrian J Wolstenholme
Journal:  Invert Neurosci       Date:  2007-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.